Silencing of BRCA1 in SUM149 revertant cells also caused SIRT inhibitior synthetic lethality, suggesting a causal relationship between BRCA1 status and SIRT inhibitor synthetic lethality, as it did in non-tumour breast epithelial MCF10A cells (Supplementary Fig. 2c, d). This evidence concerns the gene BRCA1 and neoplasm.